4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-071358
Chairman and CEO bought 7,700 shares at an average $1.48 ($11,426)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-12-22 | Purchase | +5,000 | $1.48 | $7,400 | 11,121,956 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-23 | Purchase | +1,500 | $1.50 | $2,250 | 11,123,456 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-27 | Purchase | +1,200 | $1.48 | $1,776 | 11,124,656 | D |
| Open-market purchases · 7,700 sh · avg $1.48 · $11,426 | |||||||
Loading xslF345X03/doc4.xml…